Tags

Type your tag names separated by a space and hit enter

Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation.
J Biol Chem. 2004 Aug 27; 279(35):36259-67.JB

Abstract

Fibroblast growth factors (FGFs) play an important regulatory role in skeletal development and bone formation. However, the FGF signaling mechanisms controlling osteoblast function are poorly understood. Here, we identified a role for the Src family members Lyn and Fyn in osteoblast differentiation promoted by constitutive activation of FGF receptor-2 (FGFR2). We show that the overactive FGFR2 S252W mutation induced decreased Src family kinase tyrosine phosphorylation and activity associated with decreased Lyn and Fyn protein expression in human osteoblasts. Pharmacological stimulation of Src family kinases or transfection with Lyn or Fyn vectors repressed alkaline phosphatase (ALP) up-regulation induced by overactive FGFR2. Inhibition of proteasome activity restored normal Lyn and Fyn expression and ALP activity in FGFR2 mutant osteoblasts. Immunoprecipitation studies showed that Lyn, Fyn, and FGFR2 interacted with the ubiquitin ligase c-Cbl and ubiquitin. Transfection with c-Cbl in which the RING finger was disrupted or with c-Cbl with a point mutation that abolishes the binding ability of the Cbl phosphotyrosine-binding domain restored Src kinase activity and Lyn, Fyn, and FGFR2 levels and reduced ALP up-regulation in mutant osteoblasts. Thus, constitutive FGFR2 activation induces c-Cbl-dependent Lyn and Fyn proteasome degradation, resulting in reduced Lyn and Fyn kinase activity, increased ALP expression, and FGFR2 down-regulation. This reveals a common Cbl-mediated negative feedback mechanism controlling Lyn, Fyn, and FGFR2 degradation in response to overactive FGFR2 and indicates a role for Cbl-dependent down-regulation of Lyn and Fyn in osteoblast differentiation induced by constitutive FGFR2 activation.

Authors+Show Affiliations

Laboratory of Osteoblast Biology and Pathology, INSERM U606, University Paris 7, Hôpital Lariboisière, 2 rue Ambroise Paré, 75475 Paris Cedex 10, France.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article

Language

eng

PubMed ID

15190072

Citation

Kaabeche, Karim, et al. "Cbl-mediated Degradation of Lyn and Fyn Induced By Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast Differentiation." The Journal of Biological Chemistry, vol. 279, no. 35, 2004, pp. 36259-67.
Kaabeche K, Lemonnier J, Le Mée S, et al. Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. J Biol Chem. 2004;279(35):36259-67.
Kaabeche, K., Lemonnier, J., Le Mée, S., Caverzasio, J., & Marie, P. J. (2004). Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. The Journal of Biological Chemistry, 279(35), 36259-67.
Kaabeche K, et al. Cbl-mediated Degradation of Lyn and Fyn Induced By Constitutive Fibroblast Growth Factor Receptor-2 Activation Supports Osteoblast Differentiation. J Biol Chem. 2004 Aug 27;279(35):36259-67. PubMed PMID: 15190072.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cbl-mediated degradation of Lyn and Fyn induced by constitutive fibroblast growth factor receptor-2 activation supports osteoblast differentiation. AU - Kaabeche,Karim, AU - Lemonnier,Jérome, AU - Le Mée,Sandrine, AU - Caverzasio,Joseph, AU - Marie,Pierre J, Y1 - 2004/06/09/ PY - 2004/6/11/pubmed PY - 2004/10/7/medline PY - 2004/6/11/entrez SP - 36259 EP - 67 JF - The Journal of biological chemistry JO - J Biol Chem VL - 279 IS - 35 N2 - Fibroblast growth factors (FGFs) play an important regulatory role in skeletal development and bone formation. However, the FGF signaling mechanisms controlling osteoblast function are poorly understood. Here, we identified a role for the Src family members Lyn and Fyn in osteoblast differentiation promoted by constitutive activation of FGF receptor-2 (FGFR2). We show that the overactive FGFR2 S252W mutation induced decreased Src family kinase tyrosine phosphorylation and activity associated with decreased Lyn and Fyn protein expression in human osteoblasts. Pharmacological stimulation of Src family kinases or transfection with Lyn or Fyn vectors repressed alkaline phosphatase (ALP) up-regulation induced by overactive FGFR2. Inhibition of proteasome activity restored normal Lyn and Fyn expression and ALP activity in FGFR2 mutant osteoblasts. Immunoprecipitation studies showed that Lyn, Fyn, and FGFR2 interacted with the ubiquitin ligase c-Cbl and ubiquitin. Transfection with c-Cbl in which the RING finger was disrupted or with c-Cbl with a point mutation that abolishes the binding ability of the Cbl phosphotyrosine-binding domain restored Src kinase activity and Lyn, Fyn, and FGFR2 levels and reduced ALP up-regulation in mutant osteoblasts. Thus, constitutive FGFR2 activation induces c-Cbl-dependent Lyn and Fyn proteasome degradation, resulting in reduced Lyn and Fyn kinase activity, increased ALP expression, and FGFR2 down-regulation. This reveals a common Cbl-mediated negative feedback mechanism controlling Lyn, Fyn, and FGFR2 degradation in response to overactive FGFR2 and indicates a role for Cbl-dependent down-regulation of Lyn and Fyn in osteoblast differentiation induced by constitutive FGFR2 activation. SN - 0021-9258 UR - https://www.unboundmedicine.com/medline/citation/15190072/Cbl_mediated_degradation_of_Lyn_and_Fyn_induced_by_constitutive_fibroblast_growth_factor_receptor_2_activation_supports_osteoblast_differentiation_ L2 - http://www.jbc.org/cgi/pmidlookup?view=long&pmid=15190072 DB - PRIME DP - Unbound Medicine ER -